Curis | CRIS - Current Liabilities


Curis reported $14.97M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alaunos Therapeutics USD 864K 269K Jun/2026
Amgen USD 23.23B 2.27B Sep/2026
AstraZeneca USD 31.27B 286M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
Eli Lilly USD 47B 745M Sep/2026
Exelixis USD 411.88M 49.95M Sep/2026
Gilead Sciences USD 12B 982M Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Incyte USD 1.44B 125.72M Sep/2026
Merck USD 28.8B 1.07B Sep/2026
Novartis USD 32.52B 777M Sep/2026
Pfizer USD 31.73B 920M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Takeda JPY 2.6T 161B Sep/2026
TG Therapeutics USD 268.49M 81.38M Jun/2026
Verastem USD 66.84M 5.42M Mar/2026